I was going to keep quiet about this, but I changed my mind. Alex Au at Yawning Bread recently wrote an article questioning Singapore’s push into biomedical research. (Yes, the title says stem cells, but it’s clear that the intention is to write about the entire field of biomedical engineering.) However, he’s completely and utterly missed the real issues that need to be addressed for truly incisive questioning.

To be fair, this is commentary about technical issues from a non-technical person. However, that’s still no excuse for grousing over rehashed issues that are already known to be irrelevant.

Here’s a summary of the issues over at Yawning Bread:

 

  1. Singapore has taken advantage of restrictions on research on embryonic stem cells in the US. Largely true. YB omits the adjective ‘embryonic’ initially, which is significant as the whole point of the US restrictions is the controversy over their source - human embryos. There are other kinds of stem cells, which even YB alludes to later; recently, some kinds of adult stem cells been shown to exhibit some of the desirable features of embryonic stem cells, such as pluripotency and plasticity. This may mean that this differential advantage could very quickly become obsolete, and answers YB’s later question of why Singapore appears to have focussed exclusively on embryonic stem cells.
  2. ‘World-class’ researchers who have been attracted to Singapore have left. True. However, it’s been clear from day one that such moves were largely publicity stunts that in themselves have little relevance to the actual pursuit of research. Two researchers do not constitute an entire research field, no matter how famous or accoladed. Besides, the real question is whether they are leaving purely because they got better offers, or whether there is something else involved - impatience with bureaucracy, lack of skilled workers, lack of research autonomy maybe? Those are the real issues that no one is addressing publicly.
  3. Despite available government funds, Singapore companies are only interested in making money, not research. Obvious. Companies exist to make money. Small companies do not have enough capital to invest in R&D. Startup companies are not only small, they also have unstable revenue streams to fund anything other than their core businesses. Even then, new companies can and so struggle to figure out what their niches are. R&D is a fantastically expensive endeavor. This is nothing new, and nothing worrying.
  4. Singapore is short of qualified researchers. True. It takes time to train them. YB does not carefully distinguish between medical doctors, science PhDs and others, which doesn’t quite begin to capture how much more difficult it is to produce a medical doctor or scientist as compared to, say, a doctorate-holder in English literature. It may not really cost $1,000,000 to train a science PhD, but that’s not that far off. Also, it’s not a pure numbers game. Diversity and quality matters too. A successful research effort in this day and age must necessarily bring together researchers from many different disciplines. 1,000 PhDs with degrees ranging from anthropology, chemistry, bioengineering, physics, computer science, psychology, botany, and mathematics (say) will be a far more potent mix than 1,000 PhDs in bioengineering who all worked in the same 10 labs, all of which were (say) in the race to make synthetic ribosomes. Also, it goes without saying that one shouldn’t trust a mail-order PhD.
  5. Public funding of research is a good thing, but we need more transparency. Absolutely! just as we need more transparency in a great many other governmental activities. YB uses the word “accountability”, which I am not so happy with, because there is an implicit notion of measurable outcome that is antithetical to the entire point of basic research.
  6. [A] greater effort should be made to inform the tax-payer [as to] what are the risks involved, and to provide a fair prognosis.” Impossible. While I applaud the spirit, there is absolutely no way to produce such information, even in a perfectly transparent institution. The technical data is hard to distill into a such a neat picture. It’s worth repeating - measurable outcomes are antithetical to the entire point of basic research. Basic research is what you do when you don’t know what you’re doing, and neither does anyone else, and then learning from collective mistakes and failures. There’s no other way to do basic science - one is pushing the boundaries of the known from those of the unknown. In summary: the risks will always be that money will be spent with no measurable results, and that the prognosis is always unknown. That’s just empiricism for you.
  7. The Singapore media has been trying really hard to sound like things are going fine, despite the “setbacks” outlined above. Irrelevant. YB is trying to discredit the Singapore media for jingoism by arguing that the practice of these fields of research is in trouble in Singapore. However, he is trying to diagnose the health of a field that is ill-defined and in which success is difficult to measure. Nobody can predict how an emerging field will do. Of the many things that I have issues with in the Singapore media, this is not one of them. The real fault of the media here is its inability to provide us with insightful analysis of what’s going on in this field, which YB correctly claims is difficult because the typical journalist will not be able to understand the technical issues going on.
  8. The average, otherwise well-educated citizen is ill-equipped to comprehend the technical aspects of research. Absolutely. However, I would argue that the onus is on researchers to reach out to the public and get them to understand the issues and why people would care about them. Only the researchers themselves have the potential to really understand what’s going on in their own research - often, they become the world’s sole expert in very narrow domains of accomplishment. Singapore researchers absolutely need to be more outspoken about the kinds of things that they’re working on. That doesn’t necessarily mean more science demos to bored pupils in secondary schools - it could even mean bringing the controversies into the classroom, the newspapers, open houses, and community centers. 

 

 

So much for that article. Like I said, little (if any) of this is original. I’ve certainly harped on many of these issues myself. If anything, I think YB has totally missed the boat on the real issues, which surely must include:

  1. Why are star scientists leaving? Did we piss them off? Easy come, easy go is clearly a factor, but the public deserves to know why they have left, often after consuming many, many tax dollars. If nothing else, funding agencies need to learn from their past mistakes. This means answering many, if not all of these questions:
    • Did the funding agencies have unrealistic expectations? (This certainly seemed to have been in a factor in the Johns Hopkins (Singapore) fiasco.)
    • Is the scientific endeavor overly bureaucratic in Singapore?
    • Are they having trouble finding lab supplies? Export restrictions? Long import times for vital chemicals? I’ve encountered these problems before.
    • Is lab equipment not adapted to the Singapore climate? (Mundane as it seems, I’ve experienced equipment failures due to humidity, even in the air-conditioned environment of a lab bench.)
    • Are junior staff and graduate students simply not up to snuff? (Quality matters.)
    • Are they chafing under any lack of research autonomy? (Senior scientists are used to having complete freedom over their research directions.)
  2. Is investing so much into a very few, select fields (like biomedical engineering) really appropriate? The conventional argument is that Singapore is a small country with limited resources, so it makes sense to specialize. This is complete nonsense on at least three counts. First, Singapore is not poor - it’s one of the wealthiest nations in the world, both in absolute terms and when measured on a per capita basis. We’re not Ethiopia, or even Israel. Second, researchers don’t form a zero-sum community. Specialization on a personal level is beneficial, but bringing together researchers from many different backgrounds will create many more opportunities for collaboration and mutual learning. Different fields are no longer mutually independent - it takes many different points of view to ferret out insidious assumptions, clarify contexts and reduce the risk of groupthink. Quantity is not quite as as important as quality and diversity. Third, research is inherently risky, and it’s a well-understood strategy (especially in finance) to reduce risk by diversification. Putting all our eggs in one basket can produce astronomical results, but at enormous risk of total failure. If such a strategy isn’t good enough for Temasek Holdings or GIC, why is it good enough to dictate our science policy for the foreseeable future?
  3. Non-scientists have inflated expectations of research. This is something best solved with outreach activities. Science fairs and liquid nitrogen ice cream is a little corny, but can do a lot to make science more accessible. Also, it will go far to dispel the notion that science is about learning named laws and doing lots of calculations, then checking to see if you get the correct answer.

Ok, that’s enough from me. If you have any questions, please talk to a scientist!

References

  1. Alex Au, Yawning Bread, Where are we now with stem cell research?, 2008-05-28.
  2. National Institutes of Health, Stem Cell Information, 2006-10-06. A very nice explanation of the key issues for non-experts and non-technical audiences.